| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocryst Pharmaceuticals Inc (BCRX) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. BCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.32M | $12.32M | - | |
| Pres | 902.6K | $8.39M | - | |
| Other | 398.8K | $3.71M | - | |
| CFO | 268.7K | $2.50M | - | |
| Dir | 93.2K | $866.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Jones Michael L74 | Exec. Director, Finance - Pao | Sale+OE | 8,600 | $13.01 | $111,886.00 | -43.4% | -31.9% | -52.5% | |
| Nov 14, 2022 | Babu Yarlagadda S66 | Chief Discovery Officer | Sale+OE | 31,515 | $13.88 | $437,428.20 | -9.5% | -25.1% | -61.2% | |
| Apr 18, 2022 | Abercrombie George B68 | Director | Sale+OE | 5,000 | $11.04 | $55,200.00 | -100% | +7.1% | -29.3% | |
| Apr 1, 2022 | Thackray Helen M.78 | Chief R&D Officer | Sell | 7,600 | $16.20 | $123,120.00 | -5.3% | -36.2% | -49.7% | |
| Mar 10, 2022 | Sheridan William P67 | Chief Medical Officer | Sale+OE | 161,139 | $16.88 | $2,719,492.93 | -67.6% | -35.4% | -50.8% | |
| Mar 7, 2022 | Babu Yarlagadda S66 | Chief Discovery Officer | Sell | 20,000 | $17.16 | $343,200.00 | -8.0% | -40.0% | -50.2% | |
| Mar 1, 2022 | Jones Michael L74 | Exec. Director, Finance - Pao | Sale+OE | 2,300 | $17.20 | $39,560.00 | -17.0% | -44.6% | -47.5% | |
| Feb 15, 2022 | Abercrombie George B68 | Director | Sale+OE | 5,000 | $18.50 | $92,500.00 | -100% | -54.7% | -45.8% | |
| Jan 11, 2022 | Stonehouse Jon P80 | President &CEO | Sale+OE | 184,000 | $15.04 | $2,767,360.00 | -16.9% | -33.8% | -39.0% | |
| Dec 7, 2021 | Babu Yarlagadda S66 | Chief Discovery Officer | Sale+OE | 30,100 | $12.20 | $367,220.00 | -12.3% | +42.2% | -12.2% |